Listen Now
Topics Covered
- Overview of Chronic Myelogenous Leukemia (CML)
- Current Standard of Care
- New Treatment Approaches
- Updates on Clinical Trials
- Managing Side Effects, Post Treatment Side Effects & Late Effects
- Adherence: Staying on Course with Your Treatment Plan
- The Importance of Treatment Summaries & Survivorship Care Plans
- Follow-Up with Your Oncologist & Primary Care Doctor
- Benefits of Communicating with Your Health Care Team, including Key Questions for Them
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts

Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

Neil P. Shah, MD, PhD
Edward S. Ageno Distinguished Professor in Hematology/Oncology, Director, UCSF Molecular Medicine Residency Program, Leader, Hematopoietic Malignancies Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop(81.6 KB)
Workshop Date
This workshop was originally recorded on June 11, 2019.